Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis

PURPOSE: Relapse and treatment adherence to paliperidone palmitate once-monthly (PP1M) and three-monthly (PP3M) formulations in patients with schizophrenia were evaluated and compared using health claims data. PATIENTS AND METHODS: Data (June 2015─June 2018) obtained from the MarketScan(®) Multi-Sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gang, Keenan, Alexander, Daskiran, Mehmet, Mathews, Maju, Nuamah, Isaac, Orman, Camille, Joshi, Kruti, Singh, Arun, Godet, Annabelle, Pungor, Katalin, Gopal, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495229/
https://www.ncbi.nlm.nih.gov/pubmed/34629867
http://dx.doi.org/10.2147/PPA.S322880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495229/
https://www.ncbi.nlm.nih.gov/pubmed/34629867
http://dx.doi.org/10.2147/PPA.S322880

Ejemplares similares